American Well Business Summary

American Well Corp (Amwell) operates as a leading enterprise software-as-a-service (SaaS) platform, generating revenue primarily through recurring subscription fees for its Converge platform and transaction-based clinical service fees via the Amwell Medical Group (AMG). The company’s business is segmented into its high-margin Subscription segment, which serves health systems, payers, and government entities like the U.S. Defense Health Agency, and its AMG segment, which provides on-demand and scheduled virtual care. In 2026, Amwell has completed a strategic pivot toward an API-first, infrastructure-heavy model, divesting non-core assets to focus on high-quality, sticky revenue with a target of achieving positive operating cash flow by Q4 2026. Within the competitive landscape, Amwell competes directly with Teladoc Health, Talkspace, and Hims & Hers Health; however, it distinguishes itself by positioning its technology as the underlying digital backbone for hybrid care delivery rather than a standalone consumer service. Amwell was co-founded by brothers Dr. Ido Schoenberg, who serves as Chairman and CEO, and Dr. Roy Schoenberg, the Executive Vice Chairman, both of whom have extensive pedigrees in healthcare informatics and previously led iMDSoft and TriZetto. The executive team is bolstered by CFO and COO Mark J. Hirschhorn, a veteran of Teladoc Health and TapestryHealth, and Chief Product and Technology Officer Dan Zamansky, who brought deep cloud expertise from his former leadership role at Amazon Web Services (AWS) Health AI. The company maintains a strong institutional investor base, including Morgan Stanley, Vanguard, and BlackRock, and continues to benefit from a strategic partnership with Google Cloud (Alphabet), which remains a notable stakeholder following its $100 million pre-IPO investment. The board of directors is characterized by long-tenured members with deep expertise in global healthcare operations and digital transformation.